#ESOC2025 has wrapped up after 3 days of insightful sessions, expert speakers & meaningful connections. Thanks to all who participated! 📽️ Watch the highlights video and Save the Date for #ESOC2026 in Maastricht, the Netherlands #VoiceOfStroke Maastricht Convention Bureau

Important new work on cardioaortic diagnostics in acute stroke by Luciano Sposato 🇦🇷🇨🇦 et al.!

Want to hear about the use of inflammatory biomarkers to guide secondary #stroke prevention? Click here to watch our recent interview with Gerrit M. Große of UniSpitalBaselCH from #ESOC2025 in which he provided insight into this topic: 👉 ow.ly/FpaW50W1siK #StrokeTwitter

#MondayTip Residual risk of stroke despite OAC in AF 🚨Risk Remains High: 1 in 6 patients experiencing a recurrent IS within 5y 🌎Real-world cohorts: 2x the recurrence risk vs RCT ⏰Urgent need for research to identify high-risk patients and to develop new therapeutic approaches

Direct comparison of apixaban with rivaroxaban for treatment of VTE shows excess bleeding with rivaroxaban in the COBRA randomized trial.

🚨 New in The Lancet: The CATALYST meta-analysis refines when to start anticoagulation after ischaemic stroke in #AF patients. Proud to see major contribution from Stroke Research Center Bern driving international stroke research forward! 🧠 sciencedirect.com/science/articl… Urs Martin Fischer UCL Stroke Research

Many thanks to all the CATALYST collaborators, who helped us to solve this old dilemma in acute stroke management: there is no reason to delay anticoagulants in ischemic stoke patients with atrial fibrillation! Insel Gruppe Stroke Research Center Bern Universität Bern

#ESOC2025 | Gerrit M. Große of UniSpitalBaselCH discusses the potential of analyzing retrieved thrombi from #stroke patients to identify distinct patterns of cytokine levels that can help differentiate between cerebral large vessel occlusion strokes: 🎥 ow.ly/Avb850W1smq

🚨meeting announcement 📣#BIOSTROKE meeting (📅 Feb 23-25, 2026) in the beautiful city of Munich🥨🍻🏔️. The venue is Castle Hohenkammer 🏰 and the registration fee *includes* acommodation. ESMINT Society European Stroke Org endorsed! Pls consider joining us☺️🙏 biostroke.de/biostroke

🎥 Missed it live? Revisit #ESOC2025 Day 2 PI Interviews: eso-stroke.org/esoc2025/#esoc… Marieta Peycheva Gerrit M. Große @Engelter @Ovbiagele on ✅ BP control trial in Ghana tackles stroke burden & fragmented care ✅ ESTREL tests levodopa to enhance stroke rehab in 600+ pts #VoiceOfStroke

Mark your calendars now! 📅 Save the Date: 6-8 May 2026, #ESOC2026 in Maastricht We can't wait to bring you more details this autumn, so stay tuned for updates!🔗 eso-stroke.org/esoc2026/ #Neurology #Stroke #VoiceOfStroke

⏰Deadline Today! Apply to ESO’s Emerging Leaders Programme! ESO is seeking the next generation of visionary leaders committed to advancing stroke prevention, treatment, and advocacy worldwide. 👉 ow.ly/soVC50WaKJF #Stroke #Neurology #StrokeTwitter

📢 Save the Date – Abstract Submission for #ESOC2026 Abstract submission will open earlier than in previous years. Plan ahead & prepare your research: 🗓️ Opening: 8 October 2025 🗓️ Deadline: 7 January 2026 🔗 ow.ly/RCAR50WOXRO #VoiceOfStroke #Stroke #Neurology

🧠❄️ Deadline coming up. Apply now for the 13th ESO–ESMINT–ESNR Stroke Winter School. Apply now to take part in an unparalleled training experience. Apply until 30 September🔗 ow.ly/etWk50WECke #StrokeCare #StrokeEducation Insel Gruppe #Stroke

Could the Parkinson’s drug levodopa prime the brain to respond better to intensive rehabilitation following a stroke or injury? Enter the idea: Let’s give dopamine pills after a stroke? Spoiler alert: This new large, randomized trial published in JAMA revealed no added benefit in

Special Report by Shadi Yaghi et al.: The ISPS25 classification system creates a new framework to understand #stroke etiology and permit targeted treatments and rational randomized trial design for various ischemic stroke subtypes. #AHAJournals #WSC2025 ahajrnls.org/472BjvF

The stroke field had major developments since 1993 when the TOAST criteria were proposed. We need move on to a different system that incorporates new mechanisms/tools/testing and standardizes the minimum workup. Introducing ISPS25 #stroke #WSC25 #meded ahajournals.org/doi/10.1161/ST…

Reperfusion in #stroke can be beneficial, futile, or harmful. A better understanding of the pathophysiology and overall prognosis can inform our decision-making. Stroke AHA/ASA American Heart Association Johanna Ospel, MD PhD ahajournals.org/doi/full/10.11…